Registered entities
Glyscend, Inc.
Reg. No. 472030150United States
Investor mix
7 investors on record; lead investors include Sante Ventures, Brandon Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Other / undisclosed | 2 | 29% |
Developer of orally administered barrier pill for the treatment of diabetes and obesity
7 investors on record; lead investors include Sante Ventures, Brandon Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 71% |
| Other / undisclosed | 2 | 29% |